Copertina

Accuracy of ChatGPT , Gemini, Claude and DeepSeek in Carbohydrate Counting

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Luca Zagaroli, Nicholas Caione, Sabina Zara, Federica Guerra, Antonella Zugaro, Marco Giorgio Baroni, Maria Laura Iezzi, Maurizio Delvecchio
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Diabetes, Obesity and Metabolism
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Exploring the value of ChatGPT in selecting antidiabetic agents for type 2 diabetes
di: Seol A. Jang, et al.
Pubblicazione: (2025)

REduced‐Carbohydrate intervention for managing Obesity and Reduction of gestational Diabetes ( RECORD ): A randomized controlled feasibility trial
di: Moscho Michalopoulou, et al.
Pubblicazione: (2024)

Low‐Dose Glucagon After Fasted Morning Exercise in People With Type 1 Diabetes—A Randomised Crossover Comparison of Low and High Carbohydrate Diets
di: Signe Schmidt, et al.
Pubblicazione: (2026)

Counting the lifetime cost of obesity: Analysis based on national England data
di: Adrian Heald, et al.
Pubblicazione: (2024)

Accuracy and reliability of a continuous glucose monitoring system with a focus on hypoglycaemia
di: Lukas van Baal, et al.
Pubblicazione: (2025)

Accuracy of the professional flash glucose monitoring system FreeStyle Libre Pro in hospitalized individuals with type 2 diabetes mellitus receiving standardized basal‐bolus insulin therapy
di: Felix Aberer, et al.
Pubblicazione: (2024)

Association of type III collagen turnover with cardiovascular outcomes and impact with canagliflozin in the CANVAS Program: A post hoc analysis
di: Daniel G. K. Rasmussen, et al.
Pubblicazione: (2024)

Weight‐reducing treatments are associated with an improvement in depression, functional health status, and quality of life: A meta‐analysis of randomized controlled trials
di: Giovanni Antonio Silverii, et al.
Pubblicazione: (2025)

Efficacy and safety of European Medicines Agency ( EMA )‐approved pharmacological, endoscopic, and surgical treatments in different classes of obesity: A network meta‐analysis of randomised controlled trials for the development of the SIO (Società Italiana Obesità) Italian guidelines for the diagnosis and treatment of overweight and obesity
di: Rocco Barazzoni, et al.
Pubblicazione: (2025)

Glycaemic control metrics and metabolic dysfunction–associated steatotic liver disease in children and adolescents with type 1 diabetes
di: Claudio Maffeis, et al.
Pubblicazione: (2024)

Liraglutide improves peripheral perfusion and markers of angiogenesis and inflammation in people with type 2 diabetes and peripheral artery disease: An 18‐month follow‐up of a randomized clinical trial
di: Paola Caruso, et al.
Pubblicazione: (2025)

Association of semaglutide with less limb events in people with type 2 diabetes and peripheral artery disease or foot ulcers: An observational study comparing matched cohorts
di: Paola Caruso, et al.
Pubblicazione: (2025)

The Burden of Obesity and Type 1 Diabetes: Distinct and Synergistic Effects to Worsen Perceived Health and Psychosocial Distress
di: Renata Risi, et al.
Pubblicazione: (2026)

Risk of new‐onset diabetes and efficacy of pharmacological weight loss therapy
di: Filipe A. Moura, et al.
Pubblicazione: (2024)

Meta‐analysis of randomized controlled trials for the development of the International Federation for Surgery of Obesity and Metabolic Disorders‐European Chapter (IFSO‐EC) guidelines on multimodal strategies for the surgical treatment of obesity
di: Maurizio De Luca, et al.
Pubblicazione: (2025)

Dapagliflozin and chiglitazar combination enhanced myocardial energy metabolism in high‐fat diet‐fed mice
di: Jieying Liu, et al.
Pubblicazione: (2025)

A prospective observational study to evaluate a possible relationship between vitamin K antagonist therapy and risk of peripheral arterial disease in patients with type 2 diabetes
di: Olivier Bourron, et al.
Pubblicazione: (2024)

Plasma fatty acid esters of hydroxy fatty acids and surrogate fatty acid esters of hydroxy fatty acids hydrolysis activity in children with or without obesity and in adults with or without coronary artery disease
di: Sze Min Ong, et al.
Pubblicazione: (2024)

Comparing clinical outcomes in patients with type 2 diabetes mellitus after ischaemic stroke: Sodium–glucose cotransporter 2 inhibitors users versus non‐users. A propensity score matching National Cohort Study
di: Tzu‐Yang Chen, et al.
Pubblicazione: (2024)

Association patterns of ketone bodies with the risk of adverse outcomes according to diabetes status
di: Jiang Li, et al.
Pubblicazione: (2024)

Normoalbuminuria—is it normal? The association of urinary albumin within the ‘normoalbuminuric’ range with adverse cardiovascular and mortality outcomes: A systematic review and meta‐analysis
di: Dvora R. Sehtman‐Shachar, et al.
Pubblicazione: (2024)

Serum levels of the incretin‐like peptide 26RFa are diminished in women living with obesity and diabetes and restored after sleeve gastrectomy: Results from the prospective pilot RFa ‐Ba‐S study
di: Hind Khiar, et al.
Pubblicazione: (2024)

Superior benefits of sodium‐glucose co‐transporter‐2 inhibitors compared with dipeptidyl peptidase‐4 inhibitors for diabetic kidney disease: A cohort study
di: Hsiao‐Ling Chen, et al.
Pubblicazione: (2024)

Efficacy and safety of cofrogliptin once every 2 weeks in Chinese patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled, phase 3 trial
di: Leili Gao, et al.
Pubblicazione: (2024)

Concurrent SGLT2 inhibitor use in patients with type 2 diabetes hospitalised for high‐dose corticosteroid therapy: Mitigated iatrogenic hyperglycaemia
di: Kaori Ikeda, et al.
Pubblicazione: (2025)

Long‐term adherence to glucose‐lowering medications in adults with diabetes: A data linkage study
di: Crystal M. Y. Lee, et al.
Pubblicazione: (2025)

Impact of social disadvantage on clinical and health care use indicators in adults with type 1 diabetes using insulin pumps in Ontario, Canada
di: Youstina Soliman, et al.
Pubblicazione: (2025)

Higher post‐prandial glucose excursions in youth with type 1 diabetes and celiac disease: Time to change the bolus?
di: Marco Marigliano, et al.
Pubblicazione: (2026)

Real‐world use of glucagon‐like peptide‐1 receptor agonists in youth with type 2 diabetes is associated with short‐term improvements in HbA1c
di: Stephanie L. Samuels, et al.
Pubblicazione: (2024)

Efficacy and safety of glucagon‐like peptide 1 receptor agonists across all health outcomes in type 2 diabetes: An umbrella review and evidence map of randomised controlled trials
di: Dongjin Yeo, et al.
Pubblicazione: (2025)

Global deletion of G protein‐coupled receptor 55 impairs glucose homeostasis during obesity by reducing insulin secretion and β‐cell turnover
di: Bo Liu, et al.
Pubblicazione: (2024)

Plasma proteomics identifies potential drug targets for diabetic polyneuropathy: Evidence from prospective cohorts and genetic analysis
di: Haoning Lan, et al.
Pubblicazione: (2025)

The association between glycaemic control, normal weight and long‐term macrovascular outcomes in people with type 2 diabetes in China: A retrospective study
di: Feng Sun, et al.
Pubblicazione: (2025)

Hypobaric hypoxia disrupts brown adipose thermogenic function in mice via Plin2 upregulation
di: Yajie Hu, et al.
Pubblicazione: (2025)

Real‐world insights into incretin‐based therapy: Associations between changes in taste perception and appetite regulation in individuals with obesity and overweight: A cross‐sectional study
di: Ali Kapan, et al.
Pubblicazione: (2025)

Use of NT‐proBNP for the screening, diagnosis and risk‐stratification of left ventricular dysfunction
di: Pardeep S. Jhund
Pubblicazione: (2025)

Digitally enhanced ketogenic diet versus low‐fat diet for cardio‐renal‐metabolic health in a predominantly Hispanic adult population with overweight or obesity: Pilot randomised clinical trial
di: Yan Du, et al.
Pubblicazione: (2025)

The health economics of insulin therapy: How do we address the rising demands, costs, inequalities and barriers to achieving optimal outcomes
di: Phil McEwan, et al.
Pubblicazione: (2025)

Association of Life's Essential 8 with abdominal aortic calcification and mortality among middle‐aged and older individuals
di: Gehui Ni, et al.
Pubblicazione: (2024)

Long‐term effects of a multidomain intervention on cognitive function and metabolic control in older adults with type 2 diabetes and mild cognitive impairment: A 42‐month follow‐up of the J‐ MIND ‐Diabetes study
di: Taiki Sugimoto, et al.
Pubblicazione: (2026)